NAME: Peptostreptococcus spp.
SYNONYM OR CROSS REFERENCE: P. anaerobius, P. lanceolatus, P. micros, P. parvulus, P. productus
CHARACTERISTICS: Gram-positive cocci; 0.3-2 µm in size; obligate anaerobes; non-spore forming; do not require fermentable carbohydrates; chemoorganotrophs; arranged in chains, pairs, tetrads or clumps
PATHOGENICITY: Part of normal flora of the mouth, upper respiratory tract, large intestine; opportunistic pathogens causing soft tissue infections and bacteremias; causes a variety of infections (wound infections, gangrene, puerperal fever, appendicitis, pleurisy, sinusitis, osteomyelitis, diarrhea, dental infections); intra-abdominal mixed infections following surgery; intestinal perforation or cancer may lead to liver abscess
EPIDEMIOLOGY: Worldwide
HOST RANGE: Humans, lower animals
INFECTIOUS DOSE: Not known
MODE OF TRANSMISSION: Most frequently associated with trauma
INCUBATION PERIOD: Not known
COMMUNICABILITY: Not transmitted from person-to-person
RESERVOIR: Humans, animals, soil
ZOONOSIS: None
VECTORS: None
DRUG SUSCEPTIBILITY: Susceptible to ßlactam antibiotics; new drugs linezolid and biapenem have proven efficacious
DRUG RESISTANCE: Inducible macrolide-lincosamide resistance, P. asacchorolyticus is most resistant to erythromycin; limited activity with quinolones
SUSCEPTIBILITY TO DISINFECTANTS: Susceptible to many disinfectants - 1% sodium hypochlorite, 70% ethanol, glutaraldehyde, formaldehyde, iodines
PHYSICAL INACTIVATION: Sensitive to moist heat (121° C for at least 15 min) and dry heat (160-170° C for at least 1 hour)
SURVIVAL OUTSIDE HOST: Survives well in nature, ie. soil
SURVEILLANCE: Monitor for symptoms
FIRST AID/TREATMENT: Antibiotic therapy
IMMUNIZATION: None
PROPHYLAXIS: Not usually administered
LABORATORY-ACQUIRED INFECTIONS: No reported cases of laboratory infection with Peptostreptococcus spp.
SOURCES/SPECIMENS: Blood, feces, genital secretions, respiratory specimens, wound exudates, urine
PRIMARY HAZARDS: Hazard of infection is low, however, avoid accidental parenteral inoculation, ingestion, and inhalation of infectious droplets
SPECIAL HAZARDS: None
CONTAINMENT REQUIREMENTS: Well designed laboratory with good microbiological practices; this level of containment does not allow for any additional risk that may present for those individuals who with pre-existing disease, compromised immunity or who are pregnant
PROTECTIVE CLOTHING: Laboratory coat; gloves when contact with infectious materials is unavoidable
OTHER PRECAUTIONS: None
SPILLS: Allow aerosols to settle; wearing protective clothing, gently cover spill with absorbent paper towel and apply 1% sodium hypochlorite, starting at perimeter and working towards the centre; allow sufficient contact time (30 min) before clean up
DISPOSAL: Decontaminate before disposal; steam sterilization, chemical disinfection
STORAGE: In sealed containers that are appropriately labelled
Date prepared: March, 2001
Prepared by: Office of Laboratory Security, PHAC
Although the information, opinions and recommendations contained in this Material Safety Data Sheet are compiled from sources believed to be reliable, we accept no responsibility for the accuracy, sufficiency, or reliability or for any loss or injury resulting from the use of the information. Newly discovered hazards are frequent and this information may not be completely up to date.
Copyright ©
Health Canada, 2001
To share this page just click on the social network icon of your choice.